Gleevec

See the following -

Expensive Drugs Forcing Cancer Doctors To Weigh Price

Robert Langreth | Bloomberg | May 31, 2014

...With new cancer drugs priced as high as $10,000 a month and more, and insurers tightening payment rules, patients who thought they were well covered increasingly find themselves having to make life-altering decisions about what they can afford. 

Read More »

Serious Risks and Few New Benefits from FDA-Approved Drugs

Donald W. Light | Health Affairs Blog | July 6, 2015

Over the past year, the U.S. Senate and The New York Times have been investigating the failure of the nation’s auto safety regulators to protect citizens from cars with occasionally dangerous faulty devices. But neither august institution has paid attention to the Food and Drug Administration’s (FDA) failure to protect the 170 million Americans who take prescription drugs from adverse reactions that are killing more than 2,400 people every week. Annually, prescription drugs cause over 81 million adverse reactions and result in 2.7 million hospitalizations...

Read More »

Why Chemotherapy That Costs $70,000 In The U.S. Costs $2,500 In India

Thomas Bollyky | The Atlantic | April 10, 2013

By rejecting patent applications, developing countries have kept down the costs of much-needed medications. Can they continue to do so without harming efforts to develop new drugs? Read More »